MARATTO

article · International Journal of Biology Sciences

Fight against the Resistance of Salmonella Spp. to Antibiotics: Case of the use of Plant Extracts from the Ivorian Pharmacopea

Abstract

The importance of the emergence of antimicrobial resistance has led to the search for alternative solutions, including phytotherapy. The aim of this study is to find plants from the Ivorian pharmacopoeia with antibacterial powers on Salmonella spp. strains, with a view to their use in the fight against salmonellosis. The antibacterial activity of the aqueous and ethanolic (70%) extracts of the identified plants was carried out In vitro on 3 strains of Salmonella (multi) resistant, of avian and human origin, by the method of diffusion in agar medium. The minimal inhibitory (MIC) and bactericidal (MBC) concentrations were determined by macro dilution and inoculation methods on solid medium. The results obtained show that the aqueous and ethanolic extracts of Mallotus oppositifolius and Kalanchoe crenata, and the ethanolic extract of Heterotis rotundifolia, have the best antimicrobial activities, with inhibition zone diameters ranging from 12±1 mm to 31±1 mm, MICs between 6.25 mg/mL and 50 mg/mL and MBCs ≥ 25 mg/mL. In view of these results, these plants could constitute an alternative to the use of antibiotics for the control of salmonellosis.

Research topics

  • Ethnobotanical and Medicinal Plants Studies
  • Papaya Research and Applications
  • Diverse Scientific Research Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.33545/26649926.2026.v8.i9a.984

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.